| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/13/2007 | CN1978455A Human hNDS4-iso gene sequence, and its coded protein and preparation method |
| 06/13/2007 | CN1977968A Anti-fatigue function of novel compound locust polypeptide |
| 06/13/2007 | CN1977959A Chinese medicine compound preparation for comprehensively regulating body function and its preparing method |
| 06/13/2007 | CN1977958A Chinese herbal medicine cold tea |
| 06/13/2007 | CN1977925A Cardio-cerebro micro pill for treating qi-yin insufficiency and erythrocytosis, and its preparing method |
| 06/13/2007 | CN1977918A Venous preparation and its preparing method |
| 06/13/2007 | CN1977850A Xylo-oligo saccharide tablet and its preparing method |
| 06/13/2007 | CN1977842A Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 06/13/2007 | CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977828A Injection preparation and use |
| 06/13/2007 | CN1977676A Preparing of lotus-seed milk health-care drink |
| 06/13/2007 | CN1977667A Method for preparing health-care nutrient powder |
| 06/13/2007 | CN1321131C Pig Ghrelin derivative, its encoding gene and application |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1321116C Novel azepane derivatives |
| 06/13/2007 | CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/13/2007 | CN1320929C Agents for gene therapeutic for cerebrovascular disorders |
| 06/13/2007 | CN1320924C Self-emulsifying vaccine adjuvant and preparation thereof |
| 06/13/2007 | CN1320878C Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230124 Prevent skin damage; therapy for skin disorders |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230102 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 06/12/2007 | US7230088 Compounds for dual photodiagnosis and therapy |
| 06/12/2007 | US7230086 Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices |
| 06/12/2007 | US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents |
| 06/12/2007 | US7230032 Calcium blockers to treat proliferative vitreoretinopathy |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230030 Ether, alcohol, ester, carbamate or carbonate,sulfamate or silanol substituted-3,3-diphenylpropylamine derivatives; prodrugs of antimuscarinic agents with superior pharmacokinetic properties |
| 06/12/2007 | US7230028 Dimeric compounds and their use as anti-viral agents |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230021 Therapy for immunology sensitive disease; marine animal extract |
| 06/12/2007 | US7230019 As neuroprotective agents in the therapy of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7230011 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht6 receptor |
| 06/12/2007 | US7230009 Pyridoxal analogues and methods of treatment |
| 06/12/2007 | US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists |
| 06/12/2007 | US7229993 Aryl substituted pyrimidines and the use thereof |
| 06/12/2007 | US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies. |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229982 comprises cholesterol absorption inhibitor (ezetimibe) and HMG-CoA reductase inhibitor (simvastatin), antioxidants, microcrystalline cellulose, hydroxypropyl methylcellulose, magnesium stearate and lactose; for treatment of atheroslerosis |
| 06/12/2007 | US7229965 Use of growth hormone in low dose |
| 06/12/2007 | US7229809 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 06/12/2007 | US7229629 Oxidation resistance |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229607 Treatment of respiratory disease |
| 06/12/2007 | CA2417264C Crystalline therapeutic agent |
| 06/12/2007 | CA2392674C Pyrazoloquinolinone derivatives as protein kinase c inhibitors |
| 06/12/2007 | CA2382581C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/12/2007 | CA2238410C Novel indole-2,3-dione-3-oxime derivatives |
| 06/07/2007 | WO2007064738A1 Methods of reducing adverse events associated with pirfenidone therapy |
| 06/07/2007 | WO2007064664A2 Prostaglandin ep4 agonists for the treatment of gastric conditions |
| 06/07/2007 | WO2007064304A1 Biocompatible composition and uses thereof |
| 06/07/2007 | WO2007064091A1 Pharmaceutical composition comprising p38 map kinase inhibitor for treating diseases caused by npc1 gene deficiency or self-renewal disorder of stem cells |
| 06/07/2007 | WO2007064010A1 Preventive/therapeutic agent for alzheimer's dementia |
| 06/07/2007 | WO2007063935A1 Aromatic compound |
| 06/07/2007 | WO2007063934A1 Alicyclic heterocyclic compound |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007063866A1 Novel protein and dna encoding the protein |
| 06/07/2007 | WO2007063839A1 Cyclohexane derivative |
| 06/07/2007 | WO2007063789A1 Novel catechol derivative, pharmaceutical composition containing same, and uses of those |
| 06/07/2007 | WO2007062875A1 Heteroaromatic sulfonamide prodrugs |
| 06/07/2007 | WO2007062462A1 Method for administering a skin necrosis composition to an animal |
| 06/07/2007 | WO2007043653A9 Benzimidazole-5-carboxamide derivative |
| 06/07/2007 | WO2006137106A3 Method for the potentiation of opioid analgesics effects on pain |
| 06/07/2007 | US20070129440 Polypharmacophoric agents |
| 06/07/2007 | US20070129430 Agent for enhancing the production of collagen, their preparation and use |
| 06/07/2007 | US20070129427 Novel compound and pharmaceutical composition |
| 06/07/2007 | US20070129404 kinase enzyme inhibitor 5-[4-(1-amino-1-methylethyl)phenyl]-1H-indazole, useful as a drug treating eye diseases including glaucoma |
| 06/07/2007 | US20070129398 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 06/07/2007 | US20070129397 Ester derivatives |
| 06/07/2007 | US20070129381 Pharmaceutically active pyrrolidine ester derivatives |
| 06/07/2007 | US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors |
| 06/07/2007 | US20070129371 Novel ethylenediamine derivatives |
| 06/07/2007 | US20070129366 Methods for the treatment of chronic pain and compositions therefor |
| 06/07/2007 | US20070129357 Novel crystals of fluorobenzamide derivative |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
| 06/07/2007 | US20070129289 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/07/2007 | US20070128645 Use of KIAA0172 gene in treatment and diagnosis of diseases as well as in pharmaceutical development |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128212 Ceramidase inhibitor |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128198 Compositions comprising antibodies to human fgl2 |
| 06/07/2007 | US20070128163 Adeno-associated virus-mediated delivery of angiogenic factors |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | CA2632279A1 Heteroaromatic sulfonamide prodrugs |
| 06/07/2007 | CA2631646A1 Methods of reducing adverse events associated with pirfenidone therapy |
| 06/07/2007 | CA2631343A1 The combination of omega-3 fatty acids and thyroid hormone for treating alzheimer's dementia |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/06/2007 | EP1793006A2 Nucleic acid ligands and improved methods for producing the same |
| 06/06/2007 | EP1792998A2 An unusual retrotransposon from the yeast Candida albicans |
| 06/06/2007 | EP1792983A1 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiences thereof |
| 06/06/2007 | EP1792913A1 Novel secreted and membrane-associated proteins and uses therefor |
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1792902A1 Processes for preparation of 5-(6-quinazolinyl)-furan-2-carbaldehydes |
| 06/06/2007 | EP1792898A1 Molecular chaperone function regulator |
| 06/06/2007 | EP1792629A1 Preventives/remedies for stress urinary incontinence and method of screening the same |
| 06/06/2007 | EP1792615A1 Method of screening for a visceral pain inhibitor |